RNAi Europe 2005

September 28 - 29, 2005
Hilton Hotel
Amsterdam (Holland)
Contact: Select Conferences

Cenix Participant:

Dr. Michael Hannus, Group Leader, Cell-based Discovery & Validation will speak:
"HT-RNAi-based target discovery screen for atherosclerosis using microscopy assay in human hepatoma cells"

Thursday, September 29, 2005, 11:20 am - 11:50 am

Session: RNAi in Drug Target Discovery and Validation